These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 1057909

  • 1. Effect of high dose spironolactone and chlorthalidone in essential hypertension: relation to plasma renin activity and plasma volume.
    Hunyor SN, Zweifler AJ, Hansson L, Schork MA, Ellis C.
    Aust N Z J Med; 1975 Feb; 5(1):17-24. PubMed ID: 1057909
    [Abstract] [Full Text] [Related]

  • 2. Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone.
    Vaughan ED, Laragh JH, Gavras I, Bühler FR, Gavras H, Brunner HR, Baer L.
    Am J Cardiol; 1973 Sep 20; 32(4):523-32. PubMed ID: 4729722
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C, Weidmann P, de Châtel R, Hirsch D, Reubi FC.
    Schweiz Med Wochenschr; 1977 Jan 29; 107(4):104-15. PubMed ID: 834983
    [Abstract] [Full Text] [Related]

  • 6. [Spironolactone and thiabutazide in the treatment of essential hypertension (author's transl)].
    Klump F, Braun B, Klaus D, Lemke R, Zehner J, Zöfel P.
    Dtsch Med Wochenschr; 1975 Mar 21; 100(12):577-84. PubMed ID: 1168122
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Failure of aspirin to antagonize the antihypertensive effect of spironolactone in low-renin hypertension.
    Hollifield JW.
    South Med J; 1976 Aug 21; 69(8):1034-6. PubMed ID: 785608
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diuretic therapies in low renin and normal renin essential hypertension.
    Brooks CS, Johnson CA, Kotchen JM, Kotchen TA.
    Clin Pharmacol Ther; 1977 Jul 21; 22(1):14-20. PubMed ID: 326459
    [Abstract] [Full Text] [Related]

  • 15. Plasma renin activity does not predict the antihypertensive efficacy of chlorthalidone.
    Salvetti A, Pedrinelli R, Bartolomei G, Cagianelli MA, Cinotti G, Innocenti P, Loni C, Saba G, Saba P, Papi L.
    Eur J Clin Pharmacol; 1987 Jul 21; 33(3):221-6. PubMed ID: 3319646
    [Abstract] [Full Text] [Related]

  • 16. Renin reactivity as a determinant of responsiveness to antihypertensive treatment.
    Weber MA, Lopez-Ovejero JA, Drayer JI, Case DB, Laragh JH.
    Arch Intern Med; 1977 Mar 21; 137(3):284-9. PubMed ID: 843146
    [Abstract] [Full Text] [Related]

  • 17. Disparate patterns of aldosterone response during diuretic treatment of hypertension.
    Weber MA, Drayer JI, Rev A, Laragh JH.
    Ann Intern Med; 1977 Nov 21; 87(5):558-63. PubMed ID: 921083
    [Abstract] [Full Text] [Related]

  • 18. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A, Mahgoub M, Hall M, Feely J.
    Am J Hypertens; 2005 Dec 21; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [Abstract] [Full Text] [Related]

  • 19. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
    Brown JJ, Davies DL, Ferriss JB, Fraser R, Haywood E, Lever AF, Robertson JI.
    Br Med J; 1972 Jun 24; 2(5816):729-34. PubMed ID: 4338668
    [Abstract] [Full Text] [Related]

  • 20. Changes in urinary electrolytes versus serum electrolytes during treatment of primary hypertension with chlorthalidone alone and in combination with spironolactone.
    Falch DK, Schreiner AM.
    Acta Med Scand; 1981 Jun 24; 209(1-2):111-4. PubMed ID: 7010926
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.